As a model system, we employed normal (HBEC30KT) and tumour-derived (HCC4017) cell lines from the same patient together with an isogenic progression series in which the KRAS and LKB1 lesions were artificially introduced into the normal cell background (Fig. 6a)35. Here, KRAS is linked to neoplasm.